Key result
Recent heart failure updates summarize current developments for clinicians and researchers.
Why the study?
Recent studies in heart failure have highlighted important topics including vaccination, intravenous iron supplementation, beta-blocker use in HF with LVEF >40%, and mechanical circulatory support in cardiogenic shock.
This article provides concise summaries of recently published studies relevant to heart failure specialists, covering topics like vaccination, IV iron, beta-blockers, and cardiogenic shock.
Supports informed HF decision-making amid rapid advances; leaves open optimal integration of novel therapies pending prospective trials.
This article wants to provide clinicians and researchers with short and concise summaries of recently published studies in the European Journal of Heart Failure that are of particular relevance to heart failure (HF) specialists (Figure 1).Key points are the importance of vaccination in HF and the effect of intravenous (IV) iron supplementation on risk of serious infections in HF with reduced ejection fraction (HFrEF).The use of beta-blockers (BB) in patients with HF and left ventricular ejection fraction (LVEF) >40% is discussed and a novel scoring tool to identify patients in cardiogenic shock (CS) who may benefit from mechanical circulatory support (MCS) is introduced. Effect of correcting iron deficiency on the risk of serious infection in heart failureIron deficiency (ID) is common in HF patients and IV iron improves symptoms, quality of life, reduces HF hospitalizations and
No takes yet. Share an insight, caveat, or question.
Markwirth et al. (2025) conducted a review in Heart failure. This review summarizes recent studies on vaccination, IV iron supplementation, beta-blockers, and a novel scoring tool for mechanical circulatory support in heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: